Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

76.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
76.6K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[New developments in antibiotic treatment].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine.

Expert review of vaccines·2025
Same author

Caseload, clinical spectrum and economic burden of infectious diseases in patients discharged from hospitals in Germany.

Infection·2025
Same author

Health economic burden of refractory and recurrent Clostridioides difficile infection in the inpatient setting of the German healthcare system - the IBIS Study.

The Journal of hospital infection·2025
Same author

COVID or not COVID: attributing and reporting cause of death in a community cohort.

Public health·2022
Same author

Probing sedimentation non-ideality of particulate systems using analytical centrifugation.

Soft matter·2021

Related Experiment Video

Updated: Mar 7, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.8K

[Fecal microbiota transplantation].

C Lübbert1,2, B Salzberger3, J Mössner4

  • 1Fachbereich Infektions- und Tropenmedizin, Klinik und Poliklinik für Gastroenterologie und Rheumatologie, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig AöR, Liebigstr. 20, 04103, Leipzig, Deutschland. christoph.luebbert@medizin.uni-leipzig.de.

Der Internist
|February 26, 2017
PubMed
Summary
This summary is machine-generated.

Fecal microbiota transplantation (FMT) effectively treats recurrent Clostridium difficile infections, with an 85% success rate. Further research is needed for other conditions like inflammatory bowel disease.

Keywords:
Clostridium difficileDiabetes mellitusDysbiosisInflammatory bowel diseasesObesity, morbid

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.8K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • The human intestinal microbiome plays crucial roles in host metabolism, immunity, and pathogen defense.
  • Factors like antibiotics, probiotics, diet, and fecal microbiota transplantation (FMT) significantly influence the gut microbiome.
  • FMT involves transferring fecal matter from a healthy donor to a patient to restore a balanced microbiome.

Purpose of the Study:

  • To explore the therapeutic potential of FMT in various diseases linked to microbial dysbiosis.
  • To highlight FMT as a highly effective treatment for recurrent Clostridium difficile infections (CDI).
  • To identify areas requiring further investigation, including optimal donor selection, dosage, and administration routes for FMT.

Main Methods:

  • Fecal microbiota transplantation (FMT) procedure involving the transfer of fecal microorganisms.
  • Clinical evaluation of FMT efficacy in patients with recurrent Clostridium difficile infections.
  • Review of current and potential future therapeutic applications of FMT.

Main Results:

  • FMT achieves approximately 85% success in treating recurrent Clostridium difficile infections, significantly outperforming conventional vancomycin treatment (around 30%).
  • Potential therapeutic applications for FMT in chronic inflammatory and functional bowel diseases, insulin resistance, and morbid obesity require further clinical trials.
  • Limited knowledge exists regarding optimal donor selection, dosage, and administration routes for FMT.

Conclusions:

  • FMT is a highly effective treatment for recurrent Clostridium difficile infections.
  • Further clinical trials are essential to validate FMT's efficacy for other conditions.
  • Standardization of FMT protocols, including donor selection and administration, is crucial for its broader clinical implementation and long-term safety evaluation.